Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for combined pulmonary fibrosis-emphysema syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for combined pulmonary fibrosis-emphysema syndrome.
5 publications have been identified in PubMed for combined pulmonary fibrosis-emphysema syndrome. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Zhang Z (2026). [PMID: 41985639](https://pubmed.ncbi.nlm.nih.gov/41985639/). *J Ethnopharmacol*. [Review / Meta-Analysis]
Zeng W (2025). [PMID: 41426595](https://pubmed.ncbi.nlm.nih.gov/41426595/). *Frontiers in medicine*. [Review / Meta-Analysis]
Peng S (2025). [PMID: 40837109](https://pubmed.ncbi.nlm.nih.gov/40837109/). *International journal of chronic obstructive pulmonary disease*. [Case Report / Case Series]
Teke NH (2025). [PMID: 41396111](https://pubmed.ncbi.nlm.nih.gov/41396111/). *Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG*. [Epidemiology / Natural History]
Cantor J (2024). [PMID: 39519344](https://pubmed.ncbi.nlm.nih.gov/39519344/). *International journal of molecular sciences*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 10:32 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about combined pulmonary fibrosis-emphysema syndrome